Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Operating Expenses: 2016-2024

Historic Operating Expenses for Dianthus Therapeutics (DNTH) over the last 7 years, with Dec 2024 value amounting to $108.1 million.

  • Dianthus Therapeutics' Operating Expenses rose 26.85% to $40.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.4 million, marking a year-over-year increase of 62.44%. This contributed to the annual value of $108.1 million for FY2024, which is 111.96% up from last year.
  • Per Dianthus Therapeutics' latest filing, its Operating Expenses stood at $108.1 million for FY2024, which was up 111.96% from $51.0 million recorded in FY2023.
  • Dianthus Therapeutics' Operating Expenses' 5-year high stood at $108.1 million during FY2024, with a 5-year trough of $36.1 million in FY2022.
  • In the last 3 years, Dianthus Therapeutics' Operating Expenses had a median value of $51.0 million in 2023 and averaged $65.1 million.
  • Data for Dianthus Therapeutics' Operating Expenses shows a peak YoY spiked of 111.96% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Dianthus Therapeutics' Operating Expenses stood at $36.1 million in 2022, then surged by 41.19% to $51.0 million in 2023, then spiked by 111.96% to $108.1 million in 2024.